PRESS RELEASE published on 09/28/2023 at 17:40, 1 year 2 months ago Valbiotis publishes its financial report for the first half of 2023 and confirms its strategic roadmap
PRESS RELEASE published on 09/28/2023 at 17:40, 1 year 2 months ago Valbiotis publie son rapport financier pour le premier semestre 2023 et confirme sa feuille de route stratégique
PRESS RELEASE published on 09/11/2023 at 17:40, 1 year 3 months ago VALBIOTIS SA: Valbiotis presents the full results of the Phase II/III REVERSE-IT study: impressive efficacy of TOTUM•63 against prediabetes and the early stages of type 2 diabetes
PRESS RELEASE published on 09/11/2023 at 17:40, 1 year 3 months ago VALBIOTIS SA: Valbiotis présente les résultats complets de l’étude de Phase II/III REVERSE-IT : efficacité remarquable de TOTUM•63 contre le prédiabète et les stades précoces du diabète de type 2
PRESS RELEASE published on 09/06/2023 at 17:40, 1 year 3 months ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social - Juillet 2023
PRESS RELEASE published on 09/06/2023 at 17:40, 1 year 3 months ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social - Août 2023
PRESS RELEASE published on 08/04/2023 at 17:40, 1 year 4 months ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social - Juillet 2023
PRESS RELEASE published on 07/17/2023 at 17:40, 1 year 5 months ago VALBIOTIS SA: Bilan semestriel du contrat de liquidité
PRESS RELEASE published on 07/12/2023 at 17:40, 1 year 5 months ago Valbiotis announces its roadmap and strategic priorities on the eve of key milestones for its portfolio of innovative active substances
PRESS RELEASE published on 07/12/2023 at 17:40, 1 year 5 months ago Valbiotis annonce sa feuille de route et ses priorités stratégiques, à la veille d’étapes décisives pour son portefeuille de substances actives innovantes
Published on 12/21/2024 at 01:30, 1 day 8 hours ago Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 1 day 8 hours ago iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 1 day 10 hours ago Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/20/2024 at 23:30, 1 day 10 hours ago Boron One Announces Extension to Early Warrant Exercise Incentive Program
Published on 12/21/2024 at 00:51, 1 day 9 hours ago Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/20/2024 at 19:10, 1 day 15 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day 15 hours ago CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 16 hours ago ARYZTA AG Announces New Board Technology Committee
Published on 12/21/2024 at 12:17, 21 hours 55 minutes ago AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 21 hours 55 minutes ago AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 16 hours ago Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 16 hours ago Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 16 hours ago Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024
